{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:13:28Z","timestamp":1762190008038,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Basic and Applied Basic Research Project of Guangzhou Basic Program","award":["2024A04J3325","2024A03J0451"],"award-info":[{"award-number":["2024A04J3325","2024A03J0451"]}]},{"name":"the Guangdong Basic and Applied Basic Research Foundation"},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010138"],"award-info":[{"award-number":["2024A1515010138"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jbc.2025.110320","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T15:51:07Z","timestamp":1748620267000},"page":"110320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis"],"prefix":"10.1016","volume":"301","author":[{"given":"Liping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinqiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongle","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingxuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-7164","authenticated-orcid":false,"given":"Bei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110320_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbc.2025.110320_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.787","article-title":"RNA modification in normal hematopoiesis and hematologic malignancies","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jbc.2025.110320_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary management of acute myeloid leukemia: a review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib5","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJMoa0904544","article-title":"Anthracycline dose intensification in acute myeloid leukemia","volume":"361","author":"Fernandez","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110320_bib6","first-page":"7","article-title":"CACA guidelines for holistic integrative management of adult acute myeloid leukemia","volume":"3","author":"Wei","year":"2024","journal-title":"Holist. Integr. Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jamaoncol.2018.2091","article-title":"Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse","volume":"4","author":"Kharfan-Dabaja","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib9","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110320_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-020-00361-x","article-title":"Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy","volume":"5","author":"Carter","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jbc.2025.110320_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s43018-022-00366-1","article-title":"IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia","volume":"3","author":"Aubrey","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jbc.2025.110320_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2025.110320_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2401410","article-title":"Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells","volume":"13","author":"Kawagoe","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2025.110320_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exphem.2015.05.012","article-title":"Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond","volume":"43","author":"Chen","year":"2015","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jbc.2025.110320_bib15","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1182\/blood-2011-02-334359","article-title":"DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110320_bib16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ccell.2014.10.009","article-title":"AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes","volume":"26","author":"Deshpande","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.stem.2018.10.016","article-title":"IKZF2 drives leukemia stem cell self-renewal and inhibits myeloid differentiation","volume":"24","author":"Park","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1172\/JCI82978","article-title":"MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C","volume":"126","author":"Zhu","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110320_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-021-04009-8","article-title":"SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2025.110320_bib20","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1002\/mog2.59","article-title":"Epigenetic regulation in cancer therapy: from mechanisms to clinical advances","volume":"3","author":"Tao","year":"2024","journal-title":"MedComm Oncol."},{"key":"10.1016\/j.jbc.2025.110320_bib21","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1074\/jbc.M115.709832","article-title":"Structural basis for substrate preference of SMYD3, a SET domain-containing protein lysine methyltransferase","volume":"291","author":"Fu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110320_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12915-022-01499-6","article-title":"SMYD3 associates with the NuRD (MTA1\/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells","volume":"20","author":"Yang","year":"2022","journal-title":"BMC Biol."},{"key":"10.1016\/j.jbc.2025.110320_bib23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ccell.2016.01.013","article-title":"Smyd3 is a transcriptional potentiator of multiple cancer-promoting genes and required for liver and colon cancer development","volume":"29","author":"Sarris","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13046-018-1011-0","article-title":"ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma","volume":"38","author":"Zhou","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110320_bib25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41419-022-05004-3","article-title":"S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma","volume":"13","author":"Zeng","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2025.110320_bib26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature13320","article-title":"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer","volume":"510","author":"Mazur","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110320_bib27","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkab418","article-title":"GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA","volume":"49","author":"Li","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110320_bib28","doi-asserted-by":"crossref","first-page":"8868","DOI":"10.1093\/nar\/gkv874","article-title":"Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells","volume":"43","author":"Kim","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2025.110320_bib29","doi-asserted-by":"crossref","first-page":"19867","DOI":"10.1074\/jbc.M109.021485","article-title":"Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription","volume":"284","author":"Kim","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110320_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ncb1151","article-title":"SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells","volume":"6","author":"Hamamoto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110320_bib31","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110320_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc989","article-title":"Disruption of differentiation in human cancer: AML shows the way","volume":"3","author":"Tenen","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110320_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.2020005693","article-title":"Alternative polyadenylation dysregulation contributes to the differentiation block of acute myeloid leukemia","volume":"139","author":"Davis","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110320_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-1759(00)00183-6","article-title":"Human granulocyte CD11b expression as a pharmacodynamic biomarker of inflammation","volume":"240","author":"Davis","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbc.2025.110320_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1357-2725(98)00153-8","article-title":"Cd14","volume":"31","author":"Schutt","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110320_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.stem.2020.12.005","article-title":"Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib37","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1038\/s41467-022-33189-w","article-title":"HOXA9 has the hallmarks of a biological switch with implications in blood cancers","volume":"13","author":"Talarmain","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110320_bib38","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ccell.2018.08.018","article-title":"HOXA9 reprograms the enhancer landscape to promote leukemogenesis","volume":"34","author":"Sun","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1158\/1535-7163.MCT-13-0397","article-title":"Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing beta-catenin signaling","volume":"13","author":"Jin","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110320_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41419-023-05907-9","article-title":"SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner","volume":"14","author":"Zeng","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbc.2025.110320_bib41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/ijc.32673","article-title":"SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters","volume":"146","author":"Lyu","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2025.110320_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi5921","article-title":"The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer","volume":"9","author":"Ikram","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.110320_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib44","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2012.10.012","article-title":"Revisiting global gene expression analysis","volume":"151","author":"Lov\u00e9n","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2025.110320_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825021702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825021702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:54:05Z","timestamp":1762188845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825021702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0021925825021702"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110320","relation":{},"ISSN":["0021-9258"],"issn-type":[{"type":"print","value":"0021-9258"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110320"}}